Psilocybin Treatment for Mental Health Gets Legal Framework
No abstract is available for this record.
Bibliographic context
- Journal
- Scientific American
- Date
- 2021-01-31
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-14Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Compassionate use of psilocybin for treatment-resistant depression in GermanyThe Lancet Psychiatry · 2025-09-22Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22